Enhertu
My wife has stage 4 NSCLC lung cancer with bone mets. She survived first line chemo and hit remission against the odds. Late during a year of maintenance chem (also has immunotherapy), it came back in 7 spots... chemo was stopped and soon she found out she has the mutation to take the very new targeted chemo drug Enhertu. She's sick, but we're hopeful. I am curious if anyone else has experience yet with Enhertu for lung cancer. The DOR from the company that makes it is something like 8 months, which, I think, means that if it works for you it doesn't work that long - is that right? Anyone care to educate me feel free. Thanks :) Todd
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards